Intuitive Surgical Inc
10 nominees · 4 ballot items.
Elect ten directors; advisory approval of named executive officers’ compensation (Say-on-Pay); ratify PricewaterhouseCoopers LLP as independent auditors; approve amendment and restatement of the 2010 Incentive Award Plan increasing share reserve by 5,000,000, extending term, and specifying change-in-control treatment.
Follow how the vote landed and what changed on Intuitive Surgical Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot4
- 1
Election of Directors
ManagementBoard: FORElect ten directors to serve until the 2027 Annual Meeting.
- 2
Advisory Approval of the Compensation of Named Executive Officers (Say-on-Pay
ManagementBoard: FORNon-binding advisory vote to approve compensation of the company's named executive officers as disclosed in the proxy statement.
More detail
Proposal asks shareholders to approve, on a non-binding basis, the compensation paid to Named Executive Officers as disclosed in the CD&A and compensation tables. Management seeks endorsement to validate compensation philosophy—heavy emphasis on long-term equity alignment (50% PSUs, 50% RSUs), pay-for-performance through PSUs tied to procedure growth and relative adjusted operating margin, and transition-related awards tied to CEO succession. The board recommends FOR, citing strong financial performance, shareholder engagement results (93% support in prior year), and market benchmarking. Approval supports retention, succession, and incentive alignment; a negative vote would trigger board review and potential changes. The vote is advisory only and will not directly change awards but guides future compensation decisions.
- 3
Ratification of the Appointment of Independent Registered Public Accounting Firm (PwC
ManagementBoard: FORRatify PricewaterhouseCoopers LLP as independent auditors for fiscal year ending December 31, 2026.
- 4
Approval of the Amendment and Restatement of the Amended and Restated Intuitive Surgical, Inc. 2010 Incentive Award Plan
ManagementBoard: FORApprove amendment to increase share reserve under the 2010 Plan by 5,000,000 shares to 125,350,000, extend plan term to January 29, 2036, and specify change-in-control treatment and other plan provisions.
More detail
Proposal requests shareholder approval to amend and restate the company’s long-standing equity incentive plan by increasing the available share pool by 5,000,000 shares, extending the plan term to 2036, and codifying change-in-control and other administrative mechanics. Management frames the request as necessary to retain and attract talent in competitive markets, particularly given the company’s growth and repurchases; the requested increase is about 1.4% of outstanding shares as of the record date and, combined with existing availability, is expected to fund grants through the 2027 meeting. The plan maintains governance protections: no repricing without shareholder approval, per-participant limits (750,000 shares/year), non-employee director caps, and a 1-for-2.3 counting for full-value awards. The board recommends FOR, arguing these changes are common and preserve flexibility to incentivize employees. Opponents might view the share increase as dilutive and argue for alternative cash compensation; management counters that equity aligns employees with long-term shareholder value. This is a significant governance matter because it affects dilution, retention incentives, and long-term alignment; the proposal’s design includes customary anti-dilution, transferability, and change-in-control provisions, but shareholders should weigh the incremental dilutive impact against the company’s burn rate (~0.4% for 2025) and overhang (~9.5%).
Nominees on the ballot10
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | VANGUARD CAPITAL MANAGEMENT LLC | 6.5% | 23,079,490 | $10.6B |
| 2 | STATE STREET CORP | 4.5% | 15,846,973 | $7.3B |
| 3 | PRICE T ROWE ASSOCIATES INC /MD/ | 3.4% | 12,004,776 | $5.5B |
| 4 | BlackRock, Inc. | 3.1% | 11,088,780 | $5.1B |
| 5 | Invesco Ltd. | 2.8% | 9,949,525 | $4.6B |
| 6 | Capital World Investors | 2.3% | 8,048,010 | $3.7B |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.1% | 7,359,779 | $3.4B |
| 8 | BlackRock, Inc. | 2.1% | 7,332,366 | $3.4B |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.0% | 7,233,971 | $3.3B |
| 10 | Fisher Asset Management, LLC | 1.1% | 3,852,940 | $1.8B |
Other Healthcare sector meetings6
Upcoming shareholder meetings at Intuitive Surgical Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Intuitive Surgical Inc 2026 annual meeting?
- Intuitive Surgical Inc (ISRG) holds its 2026 annual shareholder meeting on Thursday, April 30, 2026.
- What is the record date for the Intuitive Surgical Inc 2026 meeting?
- The record date for the Intuitive Surgical Inc 2026 meeting is Monday, March 2, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Intuitive Surgical Inc's 2026 meeting?
- The board is presenting 10 director nominees at the Intuitive Surgical Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Intuitive Surgical Inc 2026 meeting?
- Shareholders will vote on 4 proposals at the Intuitive Surgical Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.